Partners Capital Investment Group
DNA icon

Partners Capital Investment Group’s Ginkgo Bioworks DNA Stock Holding History

Partners Capital Investment Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,167
Closed -$42.3K – 179
2024
Q2 		$42.3K Buy
+3,167
New +$94.5K ﹤0.01% 183
2024
Q1 		– Sell
-3,167
Closed -$214K – 174
2023
Q4 		$214K Hold
3,167
– – ﹤0.01% 259
2023
Q3 		$229K Hold
3,167
– – 0.01% 221
2023
Q2 		$236K Buy
+3,167
New +$187K 0.01% 202

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Partners Capital Investment Group's DNA Position: Q3 2024 in Review

Partners Capital Investment Group sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 3,167 shares — an estimated $42.3K sold.

Partners Capital Investment Group first reported a position in DNA in Q2 2023 and held it in 4 quarters. The position peaked at $236K in Q2 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Partners Capital Investment Group reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Partners Capital Investment Group sold 3,167 Ginkgo Bioworks shares in Q3 2024, an estimated $42.3K.
  • Partners Capital Investment Group first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 4 quarters.
  • Partners Capital Investment Group's Ginkgo Bioworks position peaked at $236K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Partners Capital Investment Group's 13F filing for Q3 2024, filed 5 Nov 2024.